Digital Mammography Global Market Report 2024

The digital mammography market size has grown rapidly in recent years. It will grow from $1.74 billion in 2023 to $1.95 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The growth observed in the historical period within digital mammography can be attributed to several key factors. These include heightened awareness campaigns aimed at breast cancer, notable advancements enhancing imaging accuracy, government initiatives and screening programs promoting early detection, a rise in breast cancer incidence rates, and patient preference for digital imaging technologies due to their precision and benefits.

The digital mammography market size is expected to see rapidly grown in the next few years. It will grow to $2.91 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The anticipated growth in the forecast period within digital mammography is expected to stem from several significant factors. These include the integration of digital mammography with healthcare IT systems, a heightened focus on preventive healthcare initiatives, ongoing advancements in breast imaging techniques, the expanding geriatric population necessitating enhanced diagnostic tools, and global health initiatives promoting breast health awareness and screenings.

The digital mammography market is poised for growth, propelled by the escalating prevalence of breast cancer. As an abnormal proliferation of breast cells leading to tumor formation, breast cancer cases, as reported by the American Cancer Society in October 2022, recorded approximately 4.1 million affected American women, with 287,850 new instances of invasive breast cancer in 2022. This prevalence underscores the pivotal role of digital mammography in addressing breast cancer diagnosis and management.

Moreover, government initiatives in healthcare research and development are poised to further drive the digital mammography market. Various governmental bodies are channeling significant funds and efforts into healthcare, fostering innovation and advancement in digital mammography and related areas. Notably, the UK government's commitment of £260 million for healthcare research and manufacturing, as outlined by the Department of Health and Social Care in 2022, highlights the substantial support aimed at bolstering healthcare technologies like digital mammography. Innovation remains a central focus for key players in the digital mammography market, particularly in advancing technology such as 3D imaging. The introduction of 3D imaging technology by Dana-Farber, through its mobile mammography van in October 2021, represents a significant stride in offering state-of-the-art digital breast tomosynthesis (DBT). This cutting-edge imaging technology captures breast images from multiple angles, enhancing accuracy in breast cancer detection and diagnosis.

Strategic partnerships continue to be a key driver in propelling revenues within the digital mammography market. Collaborations between industry leaders like Hologic Inc. And Bayer, announced in September 2023, signify the concerted effort to deliver contrast-enhanced mammography (CEM) solutions. This partnership combines Hologic's advanced mammography gantries with Bayer's approved injection system, aiming to provide comprehensive contrast-enhanced mammography packages across Europe, Canada, and the Asia Pacific regions. Such collaborations endeavor to empower radiologists and enhance breast cancer diagnosis and treatment decision-making.

In November 2022, Teledyne DALSA, a Canadian company in the appliance, electrical, and electronics manufacturing sector, completed the acquisition of Sigmascreening B.V. For an undisclosed sum. This acquisition grants Teledyne DALSA exclusive access to Sigmascreening's intellectual property portfolio and advanced algorithms, encompassing innovative biomechanical attributes. Sigmascreening B.V., headquartered in the Netherlands, is renowned for its expertise in developing pioneering solutions for digital mammography and the screening of breast cancer.

Major companies operating in the digital mammography market report are Siemens Healthineers AG, Konica Minolta Inc., Philips Healthcare, Hologic Inc., Agfa-Gevaert N.V., Planmed Oy, Carestream Health Inc., Analogic Corporation, IBA Dosimetry GmbH, Barco Healthcare, Villa Sistemi Medicali, Teledyne DALSA Inc., Esaote S.p.A., Trivitron Healthcare, Fujifilm Medical Systems USA Inc., Canon Medical Systems Corp., Genoray Co. Ltd., DMS Imaging SA, Allengers Medical Systems Limited, Delphinus Medical Technologies Inc., Zebra Medical Vision Ltd., Metaltronica S.p.A., Fischer Medical Technologies LLC, IMS Internazionale Medico Scientifica Srl.

North America was the largest region in the digital mammography market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital mammography market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the digital mammography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main types of products included in digital mammography are 2D full field digital mammography tomosynthesis and 3D full field digital mammography tomosynthesis. These are used for several applications, including screening and diagnosis, which are used by various end users, such as hospitals, diagnostic centers, and others.

The digital mammography market research report is one of a series of new reports provides digital mammography market statistics, including digital mammography industry global market size, regional shares, competitors with a digital mammography market share, detailed digital mammography market segments, market trends and opportunities, and any further data you may need to thrive in the digital mammography industry. This digital mammography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital mammography market consists of revenues earned by entities by providing breast cancer screening and diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital mammography market also includes sales of X-ray tubes, detectors, and biopsy devices that are used in providing digital mammography services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.